Welcome
Support Centre
09 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Non-Hodgkins lymphoma T-cell protocol
ISRCTN ISRCTN73274643
ClinicalTrials.gov identifier
Public title Non-Hodgkins lymphoma T-cell protocol
Scientific title
Acronym N/A
Serial number at source NHL9503
Study hypothesis Not provided at time of registration
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Lymphoma (non-Hodgkins)
Participants - inclusion criteria 1. T-cell non-Hodgkin's lymphoma
2. Stages I-IV
3. Confirmed remission achieved
4. Less than 25% blasts in bone marrow
5. No circulating blasts in blood
6. Aged <18 years
Participants - exclusion criteria Patients with T-cell anaplastic lymphoma or peripheral T-cell lymphoma are excluded.
Anticipated start date 01/01/1997
Anticipated end date 28/02/2000
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants Not provided at time of registration
Interventions 1. Group A: Chemotherapy including third intensification block at 35 weeks
2. Group B: Chemotherapy without third intensification block at 35 weeks
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding 1. Cancer Research UK
2. United Kingdom Children's Cancer Study Group (UKCCSG)
Trial website
Publications
Contact name Dr  -  -
  Address UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
  City/town London
  Zip/Postcode NW1 2DA
  Country United Kingdom
  Tel +44 (0) 207 670 4723
  Fax +44 (0) 207 670 4818
  Email
Sponsor Cancer Research UK (CRUK) (UK)
  Address PO Box 123
Lincoln's Inn Fields
  City/town London
  Zip/Postcode WC2A 3PX
  Country United Kingdom
  Tel +44 (0)207 317 5186
  Fax +44 (0)207 487 4302
  Email kate.law@cancer.org.uk
  Sponsor website: http://www.cancer.org.uk
Date applied 01/07/2001
Last edited 01/02/2012
Date ISRCTN assigned 01/07/2001
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central